At a glance
ClinicalIndex Comparison RecordN/ACompleted· 97 enrolled
Drug / intervention
normal saline +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Placebo- Controlled,Randomized,Double Blind Trial of Erythropoietin Effect on Ischemic_ Reperfusion Injury in Coronary Artery Bypass Graft Surgery
Shahid Beheshti University of Medical Sciences·interventional·Posted Dec 6, 2016·Updated Oct 24, 2017
In Brief
A clinical study evaluating normal saline and erythropoietin for Myocardial Ischemic Reperfusion Injury. Completed, enrolled 97 participants across 1 site.
Detailed Summary
The aim of this trail is to assess the safety and therapeutic effects of single EPO intervention in different times during coronary surgery in changes of inflammatory response.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyocardial Ischemic Reperfusion Injury
CountriesIran
CollaboratorsPooyesh Darou
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJan 2016
First PostedDec 2016
Primary CompletionJan 2017
Study CompletionJun 2017
TodayJul 2026
First PostedDec 6, 2016
Enrollment StartJan 1, 2016
Primary CompletionJan 1, 2017
Study CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 9.6 years ago
Interventions
normal salinedrug
erythropoietindrug